Terminated OBSERVATIONAL NCT00260520

LMWH to Prevent Preeclampsia and Fetal Growth Restriction

Low Molecular Weight Heparin Vs No Treatment in Pregnant Women With Previous Preeclampsia or Fetal Growth Restriction Who Were Heterozygote for Factor V Leiden or Prothrombin Gene G20210A Mutation

Sponsor: University of Florence

Conditions Preeclampsia

Interventions Dalteparin

Updated 6 times since 2017 Last updated: Mar 3, 2006 Started: Jan 31, 2002 Completion: Dec 31, 2003

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

This trial was terminated. No reason was provided.

Other Preeclampsia trials with similar outcome

Browse all Preeclampsia trials

This observational or N/A phase trial investigates Preeclampsia and is currently terminated or withdrawn. University of Florence leads this study, which shows 6 recorded versions since 2002 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Terminated
Jul 2024 — Sep 2024 [monthly]

Terminated
Jan 2021 — Jul 2024 [monthly]

Terminated
Jun 2018 — Jan 2021 [monthly]

Terminated
Apr 2018 — Jun 2018 [monthly]

Terminated

Phase: PHASE4 → None

▶ Show 1 earlier version

Jan 2017 — Apr 2018 [monthly]

Terminated PHASE4

First recorded

Jan 2002

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University of Florence

Data source: University of Florence

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.